KAYTUS
14.5.2024 09:01:37 CEST | Business Wire | Press release
KAYTUS, a leading IT infrastructure provider, has unveiled its latest upgrade, the K24V2 multi-node server, at ISC High Performance 2024. This server supports four dual-socket nodes within a compact 2U form factor, featuring a total of eight cutting-edge Intel/AMD processors. The K24V2 incorporates advanced cooling technologies optimized for extreme computing density, offering both cold plate liquid cooling and air cooling configurations. Notably, the liquid-cooling K24V2 cools components that account for more than 80% of the total power consumption, while the air-cooled variant supports CPU cooling with a TDP of up to 400W. With its emphasis on high performance, energy efficiency, and exceptional reliability, the K24V2 is tailored for demanding tasks such as modeling, simulation, and other performance-intensive applications.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240513994533/en/
K24V2 Multi-Node Server (Photo: Business Wire)
Achieving Four Times Computing Density and Higher Performance
The K24V2 server enables support for four dual-socket nodes within a 2U form factor, allowing for independent operations between nodes. Each node is compatible with two 5th Gen Intel® Xeon® processors or the latest 4th Gen AMD EPYC™ processors. It supports memory configurations up to 5600MT/s, and each node can accommodate various networking extensions such as InfiniBand, Omni-Path Architecture, and RoCE, meeting the networking requirements for HPC clusters.
Leading Cooling Solutions for Enhanced Performance and Efficiency
The liquid-cooled configuration of the K24V2 incorporates an integrated cold plate design that covers key components including the CPU, memory, and VR (Voltage Regulator). Components accounting for more than 80% of total power consumption are liquid cooled, offering efficient cooling while balancing investment control and power usage for heat dissipation. The cold plate supports various liquid-cooling connectors like SCG 03 and DAG 03, ensuring compatibility with different liquid-cooling cabinets used in data centers. The K24V2 is capable of supporting high-temperature inlet cooling liquids of up to 45°C, with the primary loop capable of drawing intake from a natural draft cooling tower. Furthermore, engineered to operate efficiently at an industry-leading ambient temperature of 45°C, this system significantly reduces energy consumption in data center operations.
The air-cooled version of the K24V2 maximizes heat dissipation performance through a high air intake design and a customized heat sink. This variant supports high-density deployments with CPUs of up to 400W TDP, delivering ultra-high performance and dense computing power tailored for air-cooled data centers.
Ensuring Security and Reliability, Streamlining Operations and Maintenance
Aside from delivering industry-leading performance per watt, the K24V2 is highly secure and reliable. The four nodes share titanium power supply units (PSUs), and the entire system supports N+N or 3+1 redundancy configurations. The liquid-cooled version features an integrated cold plate design and undergoes rigorous inspection processes before leaving the factory, including a nitrogen pressure test to effectively prevent leaks. Notably, the liquid-cooled version can identify leaking nodes in real-time, automatically cutting off node power to ensure the safety of equipment and data assets.
The K24V2 enhances user experience by offering convenient operation and maintenance features. The four nodes support hot-swappable maintenance and feature a "button"-style node switching on the front panel. This simplifies the connection of maintenance equipment for unified operations and maintenance, reduces work in the backend hot air duct, and improves overall user-friendliness.
To learn more about the new KAYTUS K24V2 Multi-Node Server, please visit our website.
About KAYTUS
KAYTUS is a prominent provider of IT infrastructure solutions, delivering a diverse range of innovative, open, and eco-friendly products for cloud, AI, edge computing, and other emerging applications. With a customer-centric approach, KAYTUS is agile and responsive to user needs through its adaptable business model. Discover more at KAYTUS.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240513994533/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 11:18:00 CEST | Press release
Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0
FPT Launches Flezi Foundry™, Advancing AI-Augmented Delivery for Global Enterprises22.5.2026 10:11:00 CEST | Press release
Global IT corporation FPT announced the launch of Flezi Foundry™ (FPT Digital Foundry™), an AI-augmented delivery platform for software development and IT operations. Built around a governed Service-as-a-Software model, the platform combines autonomous AI agents, human expert oversight, secure infrastructure, and outcome-based delivery mechanisms to help enterprises modernize technology delivery as AI agents become part of software engineering and IT operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521235556/en/ Flezi Foundry applies Agentic Engineering, a structured delivery approach for software development and IT operations. The model brings AI agents into delivery workflows with human supervision, governance, transparency, and performance measurement built into the process. Flezi Foundry operates through two service modes: Agentic Development Lifecycle (ADLC) supports software development by using specialize
Boomi Named One of The Sunday Times Best Places to Work 202622.5.2026 08:00:00 CEST | Press release
Employee-led recognition places Boomi among the UK's top medium-sized employers, with a flight risk of just 3% against a technology sector average of 42% Boomi achieves an average employee happiness score of 86%, rated Excellent across all six dimensions of WorkL's workplace framework Flight risk of just 3%, compared to a technology sector average of 42%, reflecting exceptional levels of employee loyalty Rated Excellent for Diversity and Inclusion and Confidence in Management Boomi, the data activation company for AI, has today been named one of The Sunday Times Best Places to Work 2026 in the Medium Organisation category. The prestigious annual list, produced by The Sunday Times in partnership with global workplace analytics company WorkL, recognises the UK's finest employers based entirely on direct employee feedback, making it one of the most credible and transparent employer benchmarks in the country. This press release features multimedia. View the full release here: https://www.b
LTM Has Issued an Offer to Acquire Randstad’s Technology and Consulting Services Business in Europe and Australia to Scale Domain-Driven Solutions and AI Services22.5.2026 07:09:00 CEST | Press release
The deal would be part of a 360° partnership with Randstad involving: Proposed acquisition of USD 500M+ (€469M) business, primarily across Aerospace & Defence, Automotive, Utilities and BFS Five-year IT services partnership to drive AI-enabled transformation for Randstad’s India Global Capability Center Strategic talent MSP to support LTM’s expanding global workforce LTM and Randstad announced that LTM has issued an offer to acquire Randstad’s Technology and Consulting Servicesbusiness in France, Germany, Belgium, Luxembourg and Australia, representing USD 500+ million (€469M) in annual revenue, to scale domain-driven solutions and AI services in the region. The proposed acquisition would expand LTM’s presence in key markets, primarily across Aerospace & Defence, Automotive, Utilities and BFS. It would enable local domain expertise and complementary regional capabilities in domain-driven digital engineering, cybersecurity and IoT, supported by onshore and nearshore delivery through cen
Polpharma Biologics and Tuteur Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases22.5.2026 07:00:00 CEST | Press release
Polpharma Biologics, a leading biopharmaceutical company specializing in the development and manufacturing of biosimilars, today announced the signing of a landmark licensing agreement with Argentina-based Tuteur. Under this strategic partnership, Tuteur will obtain exclusive rights to commercialize a biosimilar for autoimmune diseases across Latin America (LATAM), excluding Brazil. Polpharma Biologics will retain full responsibility for the development and manufacturing of the biosimilar. Tuteur will be responsible for commercialization, marketing, and distribution in the licensed territories. This collaboration reflects a shared commitment to expanding patient access to high-quality, affordable biological therapies across the region. “Partnering with Tuteur represents an important step in advancing our mission to broaden access to biosimilars globally,” said Anjan Selz, CEO of Polpharma Biologics. “With their strong regional expertise and commercial capabilities in LATAM, we are well
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
